01 3Fosrenol
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 86
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 110
2021 Revenue in Millions : 86
Growth (%) : 28
Main Therapeutic Indication : Nephrology
Currency : USD
2023 Revenue in Millions : 93
2022 Revenue in Millions : 110
Growth (%) : -4
LOOKING FOR A SUPPLIER?